Bu Yeap is a Professor in the Medical School, University of Western Australia, and a consultant endocrinologist in the Department of Endocrinology and Diabetes at Fiona Stanley Hospital, Perth, Western Australia. He graduated from the Medical College of St Bartholomew’s Hospital, University of London, worked in the UK, then migrated to Australia where he completed physician and endocrinology training. He completed his PhD at the University of Western Australia in 2001, on androgen receptor gene expression in prostate and breast cancer cells. His current research focusses on epidemiological and clinical studies of hormones and health outcomes in men. These include testosterone and male ageing, the interaction between hormones, diabetes and cardiovascular risk, novel biomarkers for diabetes and cardiovascular disease, and interventions to improve cardiometabolic health. Recently he has been involved in studies of endocrine and metabolic associations of COVID-19. He provides inpatient and outpatient care at Fiona Stanley Hospital, mentors early and mid-career researchers, supervises PhD students and physician trainees, and teaches medical students. His clinical work spans general endocrinology and diabetes, with a particular interest in andrology. Bu has 270 publications including >200 original research articles. He was first author on the Endocrine Society of Australia’s Position Statement on the management of male hypogonadism published in the Medical Journal of Australia in 2016 and was a chief investigator in the Testosterone for the Prevention of Type 2 Diabetes (T4DM) trial. He was awarded South Metro Health Service Researcher of the Year in 2021. He has served on the Council of the Endocrine Society of Australia, and was ESA President-elect in 2018-20 and ESA President in 2020-22. He is a member of the Annual Meeting Steering Committee 2022-25.
